Phase
Condition
Inflammation
Obesity
Hypertriglyceridemia
Treatment
Probiotic
Placebo
Clinical Study ID
Ages 18-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-60 years
Body mass index (BMI) between 28 kg/m2 and 40 kg/m2
Waist circumference ≥ 88 cm or 35 inches for women, ≥ 102 cm or 40 inches for men
Willing to consume experimental capsules daily
Willing to prepare and consume the delivered meal kits
Do not fit any exclusion criteria
Exclusion
Exclusion Criteria:
Self-reported history of immunodeficiency, major gastrointestinal surgery, renal orliver disease, diabetes, heart disease, stroke, peripheral artery/vascular disease,cancer, eating disorders, gut-associated pathologies, autoimmune diseases,pacemaker, thyroid disease, gallbladder disease, chronic inflammatory diseases,scleroderma, blood clotting disorders, intravenous drug use
Weight changes > 10% over the last 4 weeks
Oral antibiotics and/or probiotics use up to 1 month prior to study and during study
Currently taking GLP-1 analogues (e.g., Ozempic), anti-inflammatory medications (e.g., corticosteroids), daily use of nonsteroidal anti-inflammatory drugs (NSAIDs) (occasional use is permitted), medications which primarily affect blood clotting (e.g., warfarin), or any medications that suppress the immune system.
Dairy allergy
Currently pregnant or breast-feeding
Study Design
Connect with a study center
University of Connecticut, Department of Nutritional Sciences
Storrs, Connecticut 06269
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.